Welcome to the 2022 IGCS Meeting Program Scheduling

 The Meeting will officially run on US Eastern Time (ETD/GMT-4)

      To check the meeting times to your local time Click Here

Displaying One Session

Session Type
Industry Symposia
Date
09/30/2022
Session Time
12:25 PM - 01:55 PM
Room
Hall 406
Session Description
Antibody Drug Conjugates As an Exciting New Drug Class - Industry Symposium by ImmunoGen, Inc.

Session Description:

One of the highest unmet medical needs in gynecologic cancers is platinum resistant ovarian cancer (PROC). Precision medicine in PROC is an exciting opportunity to allow physicians to help patients with cancer care treatment. In this 90-minute session, expert physician leaders will introduce ADCs, focusing on novel therapies and their mechanism of action as well as address associated ADC toxicity and mitigation strategies. Case studies will engage physicians interested in incorporating this treatment into clinical management.

Welcome and Introductions

Session Type
Industry Symposia
Date
09/30/2022
Session Time
12:25 PM - 01:55 PM
Room
Hall 406
Lecture Time
12:25 PM - 12:30 PM

ADC Technology and Biomarkers Driving Clinical Development

Session Type
Industry Symposia
Date
09/30/2022
Session Time
12:25 PM - 01:55 PM
Room
Hall 406
Lecture Time
12:30 PM - 12:45 PM

Existing data and expanding into clinical management

Session Type
Industry Symposia
Date
09/30/2022
Session Time
12:25 PM - 01:55 PM
Room
Hall 406
Presenter
Lecture Time
12:45 PM - 01:00 PM

ADC toxicities and mitigated strategies

Session Type
Industry Symposia
Date
09/30/2022
Session Time
12:25 PM - 01:55 PM
Room
Hall 406
Lecture Time
01:00 PM - 01:15 PM

Case Stories with Audience Response

Session Type
Industry Symposia
Date
09/30/2022
Session Time
12:25 PM - 01:55 PM
Room
Hall 406
Lecture Time
01:15 PM - 01:55 PM